Literature DB >> 18441012

Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Wenman Wu1, Dipali Sinha, Sergei Shikov, Calvin K Yip, Thomas Walz, Paul C Billings, James D Lear, Peter N Walsh.   

Abstract

Coagulation factor XI (FXI) is a covalent homodimer consisting of two identical subunits of 80 kDa linked by a disulfide bond formed by Cys-321 within the Apple 4 domain of each subunit. Because FXI(C321S) is a noncovalent dimer, residues within the interface between the two subunits must mediate its homodimeric structure. The crystal structure of FXI demonstrates formation of salt bridges between Lys-331 of one subunit and Glu-287 of the other subunit and hydrophobic interactions at the interface of the Apple 4 domains involving Ile-290, Leu-284, and Tyr-329. FXI(C321S), FXI(C321S,K331A), FXI(C321S,E287A), FXI(C321S,I290A), FXI(C321S,Y329A), FXI(C321S,L284A), FXI(C321S,K331R), and FXI(C321S,H343A) were expressed in HEK293 cells and characterized using size exclusion chromatography, analytical ultracentrifugation, electron microscopy, and functional assays. Whereas FXI(C321S) and FXI(C321S,H343A) existed in monomer/dimer equilibrium (K(d) approximately 40 nm), all other mutants were predominantly monomers with impaired dimer formation by analytical ultracentrifugation (K(d)=3-38 microm). When converted to the active enzyme, FXIa, all the monomeric mutants activated FIX similarly to wild-type dimeric FXIa. In contrast, these monomeric mutants could not be activated efficiently by FXIIa, thrombin, or autoactivation in the presence of dextran sulfate. We conclude that salt bridges formed between Lys-331 of one subunit and Glu-287 of the other together with hydrophobic interactions at the interface, involving residues Ile-290, Leu-284, and Tyr-329, are essential for homodimer formation. The dimeric structure of FXI is essential for normal proteolytic activation of FXI by FXIIa, thrombin, or FXIa either in solution or on an anionic surface but not for FIX activation by FXIa in solution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441012      PMCID: PMC2441546          DOI: 10.1074/jbc.M802275200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  Analysis of the activated partial thromboplastin time test using mathematical modeling.

Authors:  A E Kogan; D V Kardakov; M A Khanin
Journal:  Thromb Res       Date:  2001-02-15       Impact factor: 3.944

3.  Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.

Authors:  Dharmaraj Samuel; Hong Cheng; Paul W Riley; Adrian A Canutescu; Chandrasekaran Nagaswami; John W Weisel; Zimei Bu; Peter N Walsh; Heinrich Roder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-20       Impact factor: 11.205

4.  Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.

Authors:  D Sinha; F S Seaman; P N Walsh
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

5.  Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).

Authors:  R C Wiggins; C G Cochrane; J H Griffin
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

6.  Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency.

Authors:  J C Meijers; E W Davie; D W Chung
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

7.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

8.  Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XI.

Authors:  F A Baglia; B A Jameson; P N Walsh
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

9.  Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.

Authors:  Stephen B Smith; Ingrid M Verhamme; Mao-fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

10.  Negative Staining and Image Classification - Powerful Tools in Modern Electron Microscopy.

Authors:  Melanie Ohi; Ying Li; Yifan Cheng; Thomas Walz
Journal:  Biol Proced Online       Date:  2004-03-19       Impact factor: 3.244

View more
  16 in total

1.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

2.  Evaluation of imaging plates as recording medium for images of negatively stained single particles and electron diffraction patterns of two-dimensional crystals.

Authors:  Zongli Li; Richard K Hite; Yifan Cheng; Thomas Walz
Journal:  J Electron Microsc (Tokyo)       Date:  2009-07-30

3.  A sequential mechanism for exosite-mediated factor IX activation by factor XIa.

Authors:  Yipeng Geng; Ingrid M Verhamme; Amanda Messer; Mao-fu Sun; Stephen B Smith; S Paul Bajaj; David Gailani
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

4.  Factor XI anion-binding sites are required for productive interactions with polyphosphate.

Authors:  Y Geng; I M Verhamme; S A Smith; Q Cheng; M Sun; J P Sheehan; J H Morrissey; D Gailani
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

Review 5.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

Review 6.  The many faces of the contact pathway and their role in thrombosis.

Authors:  Rebecca S Woodruff; Bruce Sullenger; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

7.  Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.

Authors:  Patricia H Alvarenga; Xueqing Xu; Fabiano Oliveira; Andrezza C Chagas; Clarissa R Nascimento; Ivo M B Francischetti; Maria A Juliano; Luiz Juliano; Julio Scharfstein; Jesus G Valenzuela; José M C Ribeiro; John F Andersen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

Review 8.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

9.  Evolution of the contact phase of vertebrate blood coagulation.

Authors:  M B Ponczek; D Gailani; R F Doolittle
Journal:  J Thromb Haemost       Date:  2008-08-28       Impact factor: 5.824

Review 10.  Structural and functional features of factor XI.

Authors:  D Gailani; S B Smith
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.